Serum selenium and serum lipids in US adults

American Journal of Clinical Nutrition

Volumn 88, Issue 2, 2008, Pages 416-423

  Bleys, Joachim ^a   Navas Acien, Ana ^a,b   Stranges, Saverio ^c   Menke, Andy ^a   Miller III, Edgar R ^a,d   Guallar, Eliseo ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

^d CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SELENIUM; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CHOLESTEROL BLOOD LEVEL; FEMALE; HUMAN; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; TRIACYLGLYCEROL BLOOD LEVEL; UNITED STATES;

EID: 49449114480     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/88.2.416     Document Type: Article

References (45)

1. Rayman MP. The importance of selenium to human health. Lancet 2000;356:233-41.
2. Navas-Acien A, Bleys J, Guallar E. Selenium intake and cardiovascular risk: what is new? Curr Opin Lipidol 2008;19:43-9.
3. Food and Nutrition Board, Institute of Medicine. Dietary reference intakes for vitamin C, vitamin E, selenium, and carotenoids. A report of the Panel on Dietary Antioxidants and Related Compounds, Subcommittees on Upper Reference Levels of Nutrients and Interpretation and Uses of Dietary Reference Intakes, and the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. Washington, DC: National Academy Press, 2000.
4. Dhingra S, Bansal MP. Hypercholesterolemia and LDL receptor mRNA expression: modulation by selenium supplementation. Biometals 2006;19:493-501.
5. Dhingra S, Bansal MP. Modulation of hypercholesterolemia-induced alterations in apolipoprotein B and HMG-CoA reductase expression by selenium supplementation. Chem Biol Interact 2006;161:49-56.
6. Hercberg S, Bertrais S, Czernichow S, et al. Alterations of the lipid profile after 7.5 years of low-dose antioxidant supplementation in the SU. VI. MAX Study. Lipids 2005;40:335-42.
7. Zhang L, Gail MH, Wang YQ, et al. A randomized factorial study of the effects of long-term garlic and micronutrient supplementation and of 2-wk antibiotic treatment for Helicobacter pylori infection on serum cholesterol and lipoproteins. Am J Clin Nutr 2006;84:912-9.
8. Luoma PV, Sotaniemi EA, Korpela H, Kumpulainen J. Serum selenium, glutathione peroxidase activity and high-density lipoprotein cholesterol-effect of selenium supplementation. Res Commun Chem Pathol Pharmacol 1984;46:469-72.
9. Yu SY, Mao BL, Xiao P, et al. Intervention trial with selenium for the prevention of lung cancer among tin miners in Yunnan, China. A pilot study Biol Trace Elem Res 1990;24:105-8.
10. Gamez C, Ruiz-Lopez D, Artacho R, Navarro M, Puerta A, Lopez C. Serum selenium in institutionalized elderly subjects and relation to other nutritional markers. Clin Chem 1997;43:693-4.
11. Suadicani P, Hein HO, Gyntelberg F. Serum selenium concentration and risk of ischaemic heart disease in a prospective cohort study of 3000 males. Atherosclerosis 1992;96:33-42.
12. Ringstad J, Jacobsen BK, Thomassen Y. The Tromso Heart Study: relationships between the concentration of selenium in serum and risk factors for coronary heart disease. J Trace Elem Electrolytes Health Dis 1987;1:27-31.
13. Jossa F, Trevisan M, Krogh V, et al. Serum selenium and coronary heart disease risk factors in southern Italian men. Atherosclerosis 1991;87:129-34.
14. Coudray C, Roussel AM, Mainard F, Arnaud J, Favier A. Lipid peroxidation level and antioxidant micronutrient status in a pre-aging population; correlation with chronic disease prevalence in a French epidemiological study (Nantes, France). J Am Coll Nutr 1997;16:584-91.
15. Viegas-Crespo AM, Neve J, Monteiro ML, Amorim MF, Paulo OS, Halpern MJ. Selenium and lipid parameters in plasma of Portuguese subjects. J Trace Elem Electrolytes Health Dis 1994;8:119-22.
16. Lee O, Moon J, Chung Y. The relationship between serum selenium levels and lipid profiles in adult women. J Nutr Sci Vitaminol (Tokyo) 2003;49:397-404.
17. Salonen JT, Salonen R, Seppanen K, et al. Relationship of serum selenium and antioxidants to plasma lipoproteins, platelet aggregability and prevalent ischaemic heart disease in Eastern Finnish men. Atherosclerosis 1988;70:155-60.
18. Bleys J, Navas-Acien A, Guallar E. Selenium and diabetes: more bad news for supplements. Ann Intern Med 2007;147:271-2.
19. Stranges S, Marshall JR, Natarajan R, et al. Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. Ann Intern Med 2007;147:217-23.
20. Bleys J, Navas-Acien A, Guallar E. Serum selenium and diabetes in U.S. adults. Diabetes Care 2007;30:829-34.
21. National Center for Health Statistics. Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-1994. Hyattsvlle, MD: US Department of Health and Human Services, 1994. (Publication 94-1308.)
22. Gunther EW, Lewis BL, Koncikowski SM. Laboratory procedures used for the Third National Health and Nutrition Examination Survey (NHANES III) 1988-1994. Atlanta, GA: US Department of Health and Human Services, 1996;
23. Bachorik PS, Lovejoy KL, Carroll MD, Johnson CL, Albers JJ, Marcovina SM. Measurement of apolipoproteins A-I and B during the National Health and Nutrition Examination Survey (NHANES) III. Clin Chem 1994;40:1915-20.
24. Lewis SA, Hardison NW, Veillon C. Comparison of isotope dilution mass spectrometry and graphite furnace atomic absorption spectrometry with Zeeman background correction for determination of plasma selenium. Anal Chem 1986;58:1272-3.
25. Paschal DC, Kimberly MM. Automated direct determination of selenium in serum by electrothermal atomic absorption spectroscopy. Atomic Spectrosc. 1986;7:75-8.
26. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
27. Coresh J, Astor BC, McQuillan G, et al. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis 2002;39:920-9.
28. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-70.
29. Greenland S. Dose-response and trend analysis in epidemiology: alternatives to categorical analysis. Epidemiology 1995;6:356-65.
30. Bukkens SG, de Vos N, Kok FJ, Schouten EG, de Bruijn AM, Hofman A. Selenium status and cardiovascular risk factors in healthy Dutch subjects. J Am Coll Nutr 1990;9:128-35.
31. Koskinen T, Pyykko K, Kudo R, Jokela H, Punnonen R. Serum selenium, vitamin A, vitamin E and cholesterol concentrations in Finnish and Japanese postmenopausal women. Int J Vitam Nutr Res 1987;57:111-4.
32. Karita K, Yamanouchi Y, Takano T, Oku J, Kisaki T, Yano E. Associations of blood selenium and serum lipid levels in Japanese premenopausal and postmenopausal women. Menopause 2008;15:119-24.
33. Nassir F, Moundras C, Bayle D, et al. Effect of selenium deficiency on hepatic lipid and lipoprotein metabolism in the rat. Br J Nutr 1997;78:493-500.
34. Finley JW. Bioavailability of selenium from foods. Nutr Rev 2006;64:146-51.
35. Burk RF. Selenium, an antioxidant nutrient. Nutr Clin Care 2002;5:75-9.
36. Hill KE, Xia Y, Akesson B, Boeglin ME, Burk RF. Selenoprotein P concentration in plasma is an index of selenium status in selenium-deficient and selenium-supplemented Chinese subjects. J Nutr 1996;126:138-45.
37. Spallholz JE. On the nature of selenium toxicity and carcinostatic activity. Free Radic Biol Med 1994;17:45-64.
38. Spallholz JE, Palace VP, Reid TW. Methioninase and selenomethionine but not Se-methylselenocysteine generate methylselenol and superoxide in an in vitro chemiluminescent assay: implications for the nutritional carcinostatic activity of selenoamino acids. Biochem Pharmacol 2004;67:547-54.
39. Drake EN. Cancer chemoprevention: selenium as a prooxidant, not an antioxidant. Med Hypotheses 2006;67:318-22.
40. Flores-Mateo G, Navas-Acien A, Pastor-Barriuso R, Guallar E. Selenium and coronary heart disease: a meta-analysis. Am J Clin Nutr 2006;84:762-73.
41. Stranges S, Marshall JR, Trevisan M, et al. Effects of selenium supplementation on cardiovascular disease incidence and mortality: secondary analyses in a randomized clinical trial. Am J Epidemiol 2006;163:694-9.
42. Bleys J, Navas-Acien A, Guallar E. Serum selenium levels and all-cause, cancer, and cardiovascular mortality among US adults. Arch Intern Med 2008;168:404-10.
43. Bleys J, Miller ER III, Pastor-Barriuso R, Appel LJ, Guallar E. Vitamin-mineral supplementation and the progression of atherosclerosis: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2006;84:880-7.
44. Lippman SM, Goodman PJ, Klein EA, et al. Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT). J Natl Cancer Inst 2005;97:94-102.
45. Marshall JR, Sakr W, Wood D, et al. Design and progress of a trial of selenium to prevent prostate cancer among men with high-grade prostatic intraepithelial neoplasia. Cancer Epidemiol Biomarkers Prev 2006;15:1479-84.